ES2149155T3 - Peptidos sinteticos que contienen secuencias de factor viia y su utilizacion. - Google Patents
Peptidos sinteticos que contienen secuencias de factor viia y su utilizacion.Info
- Publication number
- ES2149155T3 ES2149155T3 ES91103555T ES91103555T ES2149155T3 ES 2149155 T3 ES2149155 T3 ES 2149155T3 ES 91103555 T ES91103555 T ES 91103555T ES 91103555 T ES91103555 T ES 91103555T ES 2149155 T3 ES2149155 T3 ES 2149155T3
- Authority
- ES
- Spain
- Prior art keywords
- factor viia
- sequences
- peptides
- synthetic peptides
- peptides containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA INVENCION TRATA DE PEPTIDOS SINTETICOS QUE CONTIENEN PARTES DE SECUENCIAS DETERMINADAS DEL FACTOR VIIA, SU SINTESIS Y LA UTILIZACION DE ESTE PEPTIDO PARA INMUNIZAR ANIMALES Y ELIMINAR ANTICUERPOS ESPECIFICOS, CONTRA LOS MENCIONADOS PEPTIDOS Y EL EMPLEO DE ESTOS ANTICUERPOS Y PEPTIDOS EN TERAPIA Y DIAGNOSTICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4007902A DE4007902A1 (de) | 1990-03-13 | 1990-03-13 | Synthetische peptide, die sequenzen aus faktor viia enthalten und deren verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2149155T3 true ES2149155T3 (es) | 2000-11-01 |
Family
ID=6402052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91103555T Expired - Lifetime ES2149155T3 (es) | 1990-03-13 | 1991-03-08 | Peptidos sinteticos que contienen secuencias de factor viia y su utilizacion. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5254672A (es) |
EP (1) | EP0446797B1 (es) |
JP (1) | JPH04217996A (es) |
AT (1) | ATE193707T1 (es) |
AU (1) | AU653332B2 (es) |
CA (1) | CA2038030C (es) |
DE (2) | DE4007902A1 (es) |
ES (1) | ES2149155T3 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT74873A (en) * | 1993-06-18 | 1997-02-28 | Nycomed Imaging As | Factor vii-derived peptides |
GB9312638D0 (en) * | 1993-06-18 | 1993-08-04 | Hafslund Nycomed As | Assay |
FR2940655B1 (fr) * | 2008-12-31 | 2011-02-18 | Lfb Biotechnologies | Peptides isoles de facteur vii de lapin. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR860984B (en) * | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
DE3827415A1 (de) * | 1988-08-12 | 1990-02-15 | Behringwerke Ag | Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung |
WO1990003390A1 (en) * | 1988-09-23 | 1990-04-05 | Corvas, Inc. | Peptidyl inhibitors of the initiation of coagulation |
-
1990
- 1990-03-13 DE DE4007902A patent/DE4007902A1/de not_active Withdrawn
-
1991
- 1991-03-08 DE DE59109189T patent/DE59109189D1/de not_active Expired - Lifetime
- 1991-03-08 ES ES91103555T patent/ES2149155T3/es not_active Expired - Lifetime
- 1991-03-08 AT AT91103555T patent/ATE193707T1/de not_active IP Right Cessation
- 1991-03-08 EP EP91103555A patent/EP0446797B1/de not_active Expired - Lifetime
- 1991-03-11 US US07/666,913 patent/US5254672A/en not_active Expired - Lifetime
- 1991-03-11 AU AU72758/91A patent/AU653332B2/en not_active Ceased
- 1991-03-12 JP JP3070418A patent/JPH04217996A/ja active Pending
- 1991-03-12 CA CA002038030A patent/CA2038030C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0446797B1 (de) | 2000-06-07 |
JPH04217996A (ja) | 1992-08-07 |
CA2038030A1 (en) | 1991-09-14 |
ATE193707T1 (de) | 2000-06-15 |
DE59109189D1 (de) | 2000-07-13 |
AU653332B2 (en) | 1994-09-29 |
AU7275891A (en) | 1991-09-19 |
EP0446797A2 (de) | 1991-09-18 |
EP0446797A3 (en) | 1993-04-07 |
DE4007902A1 (de) | 1991-09-19 |
US5254672A (en) | 1993-10-19 |
CA2038030C (en) | 2002-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0458079A3 (en) | Ultrasonic contrast agent, its preparation and application as diagnostic or therapeutic | |
NO982062L (no) | Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav | |
DE69129302D1 (de) | Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen | |
PT695758E (pt) | Amidas e esteres de pentapeptidos inibidores de cancro humano | |
DE122008000028I1 (de) | Therapeutische Zusammensetzungen die monoklonale Antikörper enthalten gegen den menschlichen Rezeptor für epidermalen Wachstumsfaktor | |
DE60032486D1 (de) | Prion protein peptide und deren verwendung | |
DE3750342D1 (de) | Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen. | |
ES2111031T3 (es) | Uso de preparaciones que contienen anticuerpos para la inmunosupresion. | |
DK0552296T3 (da) | Monoklonale antistoffer fra mus | |
ZA872166B (en) | Synthetic htlv-iii peptides,compositions and uses thereof | |
CY1109868T1 (el) | Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c | |
ATE110265T1 (de) | Verwendung von sigma-rezeptor-liganden zur herstellung eines anxiolytikums. | |
PT845998E (pt) | Medicamentos para imunoterapia contendo anticorpos que reconhecem de forma especifica o antigenio mhcii de um paciente a ser tratado | |
SE8403630L (sv) | Humana proteiner | |
DE69426767D1 (de) | Anti idiotypische Antikörper gegen Gonococcen und diese verwendende Verfahren und Zusammensetzungen. | |
ATA111789A (de) | Humaner monoklonaler antikörper und hybridom zur herstellung desselben | |
ATE94880T1 (de) | Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung. | |
ES2149155T3 (es) | Peptidos sinteticos que contienen secuencias de factor viia y su utilizacion. | |
ES2062067T3 (es) | Procedimiento de preparacion de alfa, omega-diaminas alifaticas, compuestos nuevos y su empleo en tincion capilar. | |
DK0649433T3 (da) | Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne. | |
DE59006159D1 (de) | Verwendung von macrolactonen als antiallergica. | |
DK316188A (da) | Sulfolipopolysaccharider som stimolatorer for den ikke specifikke forsvarsmekanisme | |
ITMI913056A0 (it) | Procedimento per la combustione catalitica del metano | |
DK0741746T3 (da) | Thymosin alpha 1-analoger | |
DE59102006D1 (de) | Verfahren zur Isolierung reiner Dinitrotoluole. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 446797 Country of ref document: ES |